UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells

References

• Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102 - 10; http://dx.doi.org/10.2337/diabetes.52.1.102; PMID: 12502499
   PubMed Web of Science ®Google Scholar
• Haataja L, Gurlo T, Huang CJ, Butler PC. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev 2008; 29:303 - 16; http://dx.doi.org/10.1210/er.2007-0037; PMID: 18314421
   PubMed Web of Science ®Google Scholar
• Gurlo T, Ryazantsev S, Huang CJ, Yeh MW, Reber HA, Hines OJ, O’Brien TD, Glabe CG, Butler PC. Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol 2010; 176:861 - 9; http://dx.doi.org/10.2353/ajpath.2010.090532; PMID: 20042670
   PubMed Web of Science ®Google Scholar
• Huang CJ, Haataja L, Gurlo T, Butler AE, Wu X, Soeller WC, Butler PC. Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide. Am J Physiol Endocrinol Metab 2007; 293:E1656 - 62; http://dx.doi.org/10.1152/ajpendo.00318.2007; PMID: 17911343
   PubMed Web of Science ®Google Scholar
• Huang CJ, Lin CY, Haataja L, Gurlo T, Butler AE, Rizza RA, Butler PC. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 2007; 56:2016 - 27; http://dx.doi.org/10.2337/db07-0197; PMID: 17475933
   PubMed Web of Science ®Google Scholar
• Laganowsky A, Liu C, Sawaya MR, Whitelegge JP, Park J, Zhao M, Pensalfini A, Soriaga AB, Landau M, Teng PK, et al. Atomic view of a toxic amyloid small oligomer. Science 2012; 335:1228 - 31; http://dx.doi.org/10.1126/science.1213151; PMID: 22403391
   PubMed Web of Science ®Google Scholar
• Bachar-Wikstrom E, Wikstrom JD, Ariav Y, Tirosh B, Kaiser N, Cerasi E, Leibowitz G. Stimulation of autophagy improves endoplasmic reticulum stress-induced diabetes. Diabetes 2013; 62:1227 - 37; http://dx.doi.org/10.2337/db12-1474; PMID: 23274896
   PubMed Web of Science ®Google Scholar
• Chu KY, Li H, Wada K, Johnson JD. Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions. Diabetologia 2012; 55:128 - 40; http://dx.doi.org/10.1007/s00125-011-2323-1; PMID: 22038515
   PubMed Web of Science ®Google Scholar
• Costes S, Huang CJ, Gurlo T, Daval M, Matveyenko AV, Rizza RA, Butler AE, Butler PC. β-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency. Diabetes 2011; 60:227 - 38; http://dx.doi.org/10.2337/db10-0522; PMID: 20980462
   PubMed Web of Science ®Google Scholar
• Costes S, Vandewalle B, Tourrel-Cuzin C, Broca C, Linck N, Bertrand G, Kerr-Conte J, Portha B, Pattou F, Bockaert J, et al. Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets. Diabetes 2009; 58:1105 - 15; http://dx.doi.org/10.2337/db08-0926; PMID: 19223597
   PubMed Web of Science ®Google Scholar
• Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, Komiya K, Azuma K, Hirose T, Tanaka K, Kominami E, et al. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab 2008; 8:325 - 32; http://dx.doi.org/10.1016/j.cmet.2008.08.009; PMID: 18840363
   PubMed Web of Science ®Google Scholar
• Jung HS, Chung KW, Won Kim J, Kim J, Komatsu M, Tanaka K, Nguyen YH, Kang TM, Yoon KH, Kim JW, et al. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab 2008; 8:318 - 24; http://dx.doi.org/10.1016/j.cmet.2008.08.013; PMID: 18840362
   PubMed Web of Science ®Google Scholar
• Kaniuk NA, Kiraly M, Bates H, Vranic M, Volchuk A, Brumell JH. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 2007; 56:930 - 9; http://dx.doi.org/10.2337/db06-1160; PMID: 17395740
   PubMed Web of Science ®Google Scholar
• López-Avalos MD, Duvivier-Kali VF, Xu G, Bonner-Weir S, Sharma A, Weir GC. Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets. Diabetes 2006; 55:1223 - 31; http://dx.doi.org/10.2337/db05-0450; PMID: 16644676
   PubMed Web of Science ®Google Scholar
• Rivera JF, Gurlo T, Daval M, Huang CJ, Matveyenko AV, Butler PC, Costes S. Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions. Cell Death Differ 2011; 18:415 - 26; http://dx.doi.org/10.1038/cdd.2010.111; PMID: 20814419
   PubMed Web of Science ®Google Scholar
• Bugliani M, Liechti R, Cheon H, Suleiman M, Marselli L, Kirkpatrick C, Filipponi F, Boggi U, Xenarios I, Syed F, et al. Microarray analysis of isolated human islet transcriptome in type 2 diabetes and the role of the ubiquitin-proteasome system in pancreatic beta cell dysfunction. Mol Cell Endocrinol 2013; 367:1 - 10; http://dx.doi.org/10.1016/j.mce.2012.12.001; PMID: 23246353
   PubMed Web of Science ®Google Scholar
• Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 1989; 246:670 - 3; http://dx.doi.org/10.1126/science.2530630; PMID: 2530630
   PubMed Web of Science ®Google Scholar
• Bilguvar K, Tyagi NK, Ozkara C, Tuysuz B, Bakircioglu M, Choi M, Delil S, Caglayan AO, Baranoski JF, Erturk O, et al. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration. Proc Natl Acad Sci U S A 2013; 110:3489 - 94; http://dx.doi.org/10.1073/pnas.1222732110; PMID: 23359680
   PubMed Web of Science ®Google Scholar
• Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson’s and Alzheimer’s diseases. J Biol Chem 2004; 279:13256 - 64; http://dx.doi.org/10.1074/jbc.M314124200; PMID: 14722078
   PubMed Web of Science ®Google Scholar
• Maraganore DM, Lesnick TG, Elbaz A, Chartier-Harlin MC, Gasser T, Krüger R, Hattori N, Mellick GD, Quattrone A, Satoh J, et al, UCHL1 Global Genetics Consortium. UCHL1 is a Parkinson’s disease susceptibility gene. Ann Neurol 2004; 55:512 - 21; http://dx.doi.org/10.1002/ana.20017; PMID: 15048890
   PubMed Web of Science ®Google Scholar
• Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 1999; 23:47 - 51; http://dx.doi.org/10.1038/12647; PMID: 10471497
   PubMed Web of Science ®Google Scholar
• Walters BJ, Campbell SL, Chen PC, Taylor AP, Schroeder DG, Dobrunz LE, Artavanis-Tsakonas K, Ploegh HL, Wilson JA, Cox GA, et al. Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity. Mol Cell Neurosci 2008; 39:539 - 48; http://dx.doi.org/10.1016/j.mcn.2008.07.028; PMID: 18771733
   PubMed Web of Science ®Google Scholar
• Wang XF, Li S, Chou AP, Bronstein JM. Inhibitory effects of pesticides on proteasome activity: implication in Parkinson’s disease. Neurobiol Dis 2006; 23:198 - 205; http://dx.doi.org/10.1016/j.nbd.2006.02.012; PMID: 16626962
   PubMed Web of Science ®Google Scholar
• Thayer KA, Heindel JJ, Bucher JR, Gallo MA. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ Health Perspect 2012; 120:779 - 89; http://dx.doi.org/10.1289/ehp.1104597; PMID: 22296744
   PubMed Web of Science ®Google Scholar
• Borodovsky A, Ovaa H, Kolli N, Gan-Erdene T, Wilkinson KD, Ploegh HL, Kessler BM. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem Biol 2002; 9:1149 - 59; http://dx.doi.org/10.1016/S1074-5521(02)00248-X; PMID: 12401499
   PubMed Web of Science ®Google Scholar
• Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011; 13:184 - 90; http://dx.doi.org/10.1038/ncb0311-184; PMID: 21364565
   PubMed Web of Science ®Google Scholar
• Weir GC, Bonner-Weir S. A dominant role for glucose in beta cell compensation of insulin resistance. J Clin Invest 2007; 117:81 - 3; http://dx.doi.org/10.1172/JCI30862; PMID: 17200709
   PubMed Web of Science ®Google Scholar
• Bonner C, Bacon S, Concannon CG, Rizvi SR, Baquié M, Farrelly AM, Kilbride SM, Dussmann H, Ward MW, Boulanger CM, et al. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells. Diabetes 2010; 59:2799 - 808; http://dx.doi.org/10.2337/db09-1478; PMID: 20682686
   PubMed Web of Science ®Google Scholar
• Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell 2009; 34:259 - 69; http://dx.doi.org/10.1016/j.molcel.2009.04.026; PMID: 19450525
   PubMed Web of Science ®Google Scholar
• Mizushima N. Autophagy: process and function. Genes Dev 2007; 21:2861 - 73; http://dx.doi.org/10.1101/gad.1599207; PMID: 18006683
   PubMed Web of Science ®Google Scholar
• Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 2004; 117:2805 - 12; http://dx.doi.org/10.1242/jcs.01131; PMID: 15169837
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007; 131:1149 - 63; http://dx.doi.org/10.1016/j.cell.2007.10.035; PMID: 18083104
   PubMed Web of Science ®Google Scholar
• Waguri S, Komatsu M. Biochemical and morphological detection of inclusion bodies in autophagy-deficient mice. Methods Enzymol 2009; 453:181 - 96; http://dx.doi.org/10.1016/S0076-6879(08)04009-3; PMID: 19216907
   PubMed Web of Science ®Google Scholar
• Kuma A, Matsui M, Mizushima N. LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy 2007; 3:323 - 8; PMID: 17387262
   PubMed Web of Science ®Google Scholar
• Shvets E, Elazar Z. Autophagy-independent incorporation of GFP-LC3 into protein aggregates is dependent on its interaction with p62/SQSTM1. Autophagy 2008; 4:1054 - 6; PMID: 18776740
   PubMed Web of Science ®Google Scholar
• Tanida I, Yamaji T, Ueno T, Ishiura S, Kominami E, Hanada K. Consideration about negative controls for LC3 and expression vectors for four colored fluorescent protein-LC3 negative controls. Autophagy 2008; 4:131 - 4; PMID: 18000393
   PubMed Web of Science ®Google Scholar
• Tan JM, Wong ES, Kirkpatrick DS, Pletnikova O, Ko HS, Tay SP, Ho MW, Troncoso J, Gygi SP, Lee MK, et al. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 2008; 17:431 - 9; http://dx.doi.org/10.1093/hmg/ddm320; PMID: 17981811
   PubMed Web of Science ®Google Scholar
• Costes S, Langen R, Gurlo T, Matveyenko AV, Butler PC. β-Cell failure in type 2 diabetes: a case of asking too much of too few?. Diabetes 2013; 62:327 - 35; http://dx.doi.org/10.2337/db12-1326; PMID: 23349537
   PubMed Web of Science ®Google Scholar
• Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44:863 - 70; http://dx.doi.org/10.2337/diab.44.8.863; PMID: 7621989
   PubMed Web of Science ®Google Scholar
• Fonseca SG, Gromada J, Urano F. Endoplasmic reticulum stress and pancreatic β-cell death. Trends Endocrinol Metab 2011; 22:266 - 74; PMID: 21458293
   PubMed Web of Science ®Google Scholar
• Robertson RP. Beta-cell deterioration during diabetes: what’s in the gun?. Trends Endocrinol Metab 2009; 20:388 - 93; http://dx.doi.org/10.1016/j.tem.2009.05.004; PMID: 19748794
   PubMed Web of Science ®Google Scholar
• Kagara I, Enokida H, Kawakami K, Matsuda R, Toki K, Nishimura H, Chiyomaru T, Tatarano S, Itesako T, Kawamoto K, et al. CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma. J Urol 2008; 180:343 - 51; http://dx.doi.org/10.1016/j.juro.2008.02.044; PMID: 18499164
   PubMed Web of Science ®Google Scholar
• Bartoszewski R, Rab A, Twitty G, Stevenson L, Fortenberry J, Piotrowski A, Dumanski JP, Bebok Z. The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response. J Biol Chem 2008; 283:12154 - 65; http://dx.doi.org/10.1074/jbc.M707610200; PMID: 18319256
   PubMed Web of Science ®Google Scholar
• Kabuta T, Setsuie R, Mitsui T, Kinugawa A, Sakurai M, Aoki S, Uchida K, Wada K. Aberrant molecular properties shared by familial Parkinson’s disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum Mol Genet 2008; 17:1482 - 96; http://dx.doi.org/10.1093/hmg/ddn037; PMID: 18250096
   PubMed Web of Science ®Google Scholar
• Driver JA, Smith A, Buring JE, Gaziano JM, Kurth T, Logroscino G. Prospective cohort study of type 2 diabetes and the risk of Parkinson’s disease. Diabetes Care 2008; 31:2003 - 5; http://dx.doi.org/10.2337/dc08-0688; PMID: 18599528
   PubMed Web of Science ®Google Scholar
• Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson’s disease. Diabetes Care 2007; 30:842 - 7; http://dx.doi.org/10.2337/dc06-2011; PMID: 17251276
   PubMed Web of Science ®Google Scholar
• Janson J, Laedtke T, Parisi JE, O’Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004; 53:474 - 81; http://dx.doi.org/10.2337/diabetes.53.2.474; PMID: 14747300
   PubMed Web of Science ®Google Scholar
• Sandyk R. The relationship between diabetes mellitus and Parkinson’s disease. Int J Neurosci 1993; 69:125 - 30; http://dx.doi.org/10.3109/00207459309003322; PMID: 8082998
   PubMedGoogle Scholar
• Ramesh Babu J, Lamar Seibenhener M, Peng J, Strom AL, Kemppainen R, Cox N, Zhu H, Wooten MC, Diaz-Meco MT, Moscat J, et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem 2008; 106:107 - 20; http://dx.doi.org/10.1111/j.1471-4159.2008.05340.x; PMID: 18346206
   PubMed Web of Science ®Google Scholar
• Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171:603 - 14; http://dx.doi.org/10.1083/jcb.200507002; PMID: 16286508
   PubMed Web of Science ®Google Scholar
• Korolchuk VI, Mansilla A, Menzies FM, Rubinsztein DC. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell 2009; 33:517 - 27; http://dx.doi.org/10.1016/j.molcel.2009.01.021; PMID: 19250912
   PubMed Web of Science ®Google Scholar
• Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 2009; 137:1001 - 4; http://dx.doi.org/10.1016/j.cell.2009.05.023; PMID: 19524504
   PubMed Web of Science ®Google Scholar
• Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A 1996; 93:7283 - 8; http://dx.doi.org/10.1073/pnas.93.14.7283; PMID: 8692984
   PubMed Web of Science ®Google Scholar
• Bifsha P, Landry K, Ashmarina L, Durand S, Seyrantepe V, Trudel S, Quiniou C, Chemtob S, Xu Y, Gravel RA, et al. Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway. Cell Death Differ 2007; 14:511 - 23; http://dx.doi.org/10.1038/sj.cdd.4402013; PMID: 16888648
   PubMed Web of Science ®Google Scholar
• Kabuta T, Wada K. Insights into links between familial and sporadic Parkinson’s disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy. Autophagy 2008; 4:827 - 9; PMID: 18635949
   PubMed Web of Science ®Google Scholar
• Kabuta T, Furuta A, Aoki S, Furuta K, Wada K. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J Biol Chem 2008; 283:23731 - 8; http://dx.doi.org/10.1074/jbc.M801918200; PMID: 18550537
   PubMed Web of Science ®Google Scholar